A survey of prescriber perceptions about the prevention of stress-related mucosal bleeding in the intensive care unit

Journal of Clinical Pharmacy and Therapeutics

Volumn 39, Issue 6, 2014, Pages 658-662

  Preslaski, C R ^a   Mueller, S W ^b   Kiser, T H ^b   Fish, D N ^b   MacLaren, R ^b  

^a DENVER HEALTH MEDICAL CENTER   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

Clostridium difficile; Critical care; Histamine antagonist; Pneumonia; Proton pump inhibitor; Risk factors; Stress ulcer; Survey

Indexed keywords

ANTACID AGENT; ANTICOAGULANT AGENT; CORTICOSTEROID; HISTAMINE H2 RECEPTOR ANTAGONIST; NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR; SUCRALFATE; ANTIULCER AGENT;

ACUTE LIVER FAILURE; ARTICLE; ARTIFICIAL VENTILATION; BLOOD CLOTTING DISORDER; BURN; CHEMOPROPHYLAXIS; CLINICAL EVALUATION; CLINICAL PRACTICE; CLOSTRIDIUM DIFFICILE INFECTION; DISEASE ASSOCIATION; DRUG DOSE REGIMEN; DRUG USE; ENTERIC FEEDING; EXTUBATION; HEALTH PERSONNEL ATTITUDE; HEALTH SURVEY; HELICOBACTER INFECTION; HOSPITAL INFECTION; HUMAN; INTENSIVE CARE; INTENSIVE CARE UNIT; ISCHEMIA; MAJOR CLINICAL STUDY; MUCOSAL BLEEDING; MUCOSAL ISCHEMIA; NEUROLOGIC DISEASE; PATIENT RISK; PEPTIC ULCER; PNEUMONIA; QUESTIONNAIRE; REPERFUSION INJURY; RISK ASSESSMENT; RISK FACTOR; SEPSIS; SHOCK; STOMACH MOTILITY; STRESS RELATED MUCOSAL BLEEDING; STRESS ULCER; STRESS ULCER PROPHYLAXIS; THROMBOCYTOPENIA; CROSS-SECTIONAL STUDY; GASTROINTESTINAL HEMORRHAGE; HEALTH CARE SURVEY; PHYSIOLOGICAL STRESS; PROCEDURES; STATISTICS AND NUMERICAL DATA; TIME; UNITED STATES;

ANTI-ULCER AGENTS; ATTITUDE OF HEALTH PERSONNEL; CROSS-SECTIONAL STUDIES; GASTROINTESTINAL HEMORRHAGE; HEALTH CARE SURVEYS; HUMANS; INTENSIVE CARE; INTENSIVE CARE UNITS; PEPTIC ULCER; PHYSICIAN'S PRACTICE PATTERNS; QUESTIONNAIRES; RISK ASSESSMENT; RISK FACTORS; STRESS, PHYSIOLOGICAL; TIME FACTORS; UNITED STATES;

EID: 84912042383     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/jcpt.12208     Document Type: Article

References (24)

1. American Society of Health-System Pharmacists. ASHP therapeutics guidelines on stress ulcer prophylaxis. Am J Health Syst Pharm, 1999;56:347-379.
2. Krag M, Perner A, Wetterslev J et al. Stress ulcer prophylaxis in the intensive care unit: is it indicated? A topical systematic review. Acta Anaesthesiol Scand, 2013;57:835-847.
3. Cook DJ, Griffith LE, Walter SD et al. Canadian Critical Care Trials Group. The attributable mortality and length of intensive care unit stay of clinically important gastrointestinal bleeding in critically ill patients. Crit Care, 2001;5:368-375.
4. Pimental M, Roberts DE, Bernstein CN et al. Clinically significant gastrointestinal bleeding in critically ill patients in an era of prophylaxis. Am J Gastroenterol, 2000;95:2801-2806.
5. Cook D, Heyland D, Griffith L et al. Risk factors for clinically important upper gastrointestinal bleeding in patients requiring mechanical ventilation. Crit Care Med, 1999;27:2812-2817.
6. Cook DJ, Fuller HD, Guyatt GH et al. Risk factors forgastrointestinal bleedingin critically ill patients. N Engl J Med, 1994;330:377-381.
7. MacLaren R, Allen R, Reynolds P. Risk factors for gastrointestinal hemorrhage, pneumonia, and Clostridium diffi cile infection in mechanically ventilated patients: outcomes of a large epidemiological cohort study. JAMA Intern Med, 2014;174:564-574.
8. Lat I, Micek S, Janzen J et al. Off-label medication use in adult critical care patients. J Crit Care, 2011;26:89-94.
9. Alhazzani W, Alenezi F, Jaeschke RZ et al. Proton pump inhibitors vs. histamine 2 receptor antagonists for stress ulcer prophylaxis in critically ill patients: a systematic review and meta-analysis. Crit Care Med, 2013;41:693-705.
10. Lin PC, Chang CH, Hsu PI et al. The efficacy and safety of proton pump inhibitors vs histamine-2 receptor antagonists for stress ulcer bleeding prophylaxis among critical care patients: a meta-analysis. Crit Care Med, 2010;38:1197-205.
11. Barkun AN, Bardou M, Pham CQ et al. Proton pump inhibitors vs. histamine 2 receptor antagonists for stress-related mucosal bleeding prophylaxis in critically ill patients: a meta-analysis. Am J Gastroenterol, 2012;107:507-520; quiz 521.
12. Eom CS, Jeon CY, Lim JW et al. Use of acid-suppressive drugs and risk of pneumonia: a systematic review and meta-analysis. CMAJ, 2011;183:310-319.
13. Herzig SJ, Howell MD, Ngo LH, Marcantonio ER. Acid-suppressive medication use and the risk for hospital-acquired pneumonia. JAMA, 2009;301:2120-2128.
14. Kwok CS, Arthur AK, Anibueze CI et al. Risk of Clostridium difficile infection with acid suppressing drugs and antibiotics: meta-analysis. Am J Gastroenterol, 2012;107:1011-1019.
15. Howell MD, Novack V, Grgurich P et al. Iatrogenic gastric acid suppression and the risk of nosocomial Clostridium difficile infection. Arch Intern Med, 2010;170:784-790.
16. Freedberg DA, Salmasian H, Friedman C et al. Proton pump inhibitors and risk for recurrent Clostridium difficile infection among inpatients. Am J Gastroenterol, 2013;108:1794-1801.
17. Marik PE, Vasu T, Hirani A, Pachinburavan M. Stress ulcer prophylaxis in the new millennium: a systematic review and metaanalysis. Crit Care Med, 2010;38:2222-2228.
18. Whitman C, Patel J, Patel B et al. Ventilator-associated pneumonia risk between proton pump inhibitors and histamine antagonists. Crit Care Med, 2013;41(Suppl.):884 (abstr).
19. Chanpura T, Yende S. Weighing risks and benefits of stress ulcer prophylaxis in critically ill patients. Crit Care, 2012;16:322.
20. Daley RJ, Rebuck JA, Welage LS et al. Prevention of stress ulceration: current trends in critical care. Crit Care Med, 2004;32:2008-2013.
21. Lam NP, Le PT, Crawford SY et al. National survey of stress ulcer prophylaxis. Crit Care Med, 1999;27:98-103.
22. Erstad BL, Barletta JF, Jacobi J et al. Survey of stress ulcer prophylaxis. Crit Care, 1999;3:145-149.
23. Cook D, Guyatt G, Marshall J et al. A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. N Engl J Med, 1998;338:791-797.
24. Cook DJ, Reeve BK, Guyatt GH et al. Stress ulcer prophylaxis in critically ill. Resolving discordant meta-analyses. JAMA, 1996;275:308-314.